Role of host and viral factors and genetic variation of IL28B on therapy outcome in patients with chronic hepatitis C genotype 1b from Serbia

Role of host and viral factors and genetic variation of IL28B on therapy outcome in patients with chronic hepatitis C genotype 1b from Serbia

Show other versions (1)

In hepatitis C virus (HCV) infection viral and host factors can influence therapy outcome to pegylated interferon/ribavirin (PEG-IFN/RBV) and progression of liver fibrosis. Although novel direct-acting antivirals (DAAs) show newly successful treatment of hepatitis C infection, the majority of patie...

Full description

Bibliographic Details
Main Authors: Snežana Jovanović-Ćupić, Nina Petrović, Milena Krajnović, Maja Bundalo, Nikola Kokanov, Ana Božović, Gorana Stamenković
Format: Article
Language:English
Published: University of Sarajevo, Institute for Genetic Engineering and Biotechnology 2019-06-01
Series:Genetics & Applications
Subjects:
Hepatitis C virus (HCV)
genotype 1b
IL28B polymorphism
response to therapy
liver fibrosis
Online Access:https://genapp.ba/editions/index.php/journal/article/view/44

Internet

https://genapp.ba/editions/index.php/journal/article/view/44

Similar Items